'김갑성' 기자의 전체기사
-
Babies Bliss Establishes a New Standard for Fertility Wellness…
Singapore-based Fertility Wellness House positions complementary care as long-term support alongside IVF and assisted fertility treatments SINGAPORE, Jan. 5, 2026 -- Babies Bliss, a leading fertility wellness house in Singapore, is redefining how fertility journeys are supported through a whole-person, cycle-aware fertility wellness model designed to complement medical fertility treatments such as IUI and IVF. As more women and couples navigate prolonged fertility journeys, IVF fatigue, and the emotional strain of repeated treatment cycles, demand is rising for non-medical, supp
- 김갑성 기자
- 2026-01-05 07:00
-
Daingt Co., Ltd. Launches New Gim Products Based on Raw…
SEOUL, South Korea, Jan. 4, 2026 -- Daingt Co., Ltd. announced the launch of new gim (seaweed) products developed based on its accumulated production experience and raw material data. The newly introduced products were developed by actively leveraging Daingt's extensive database of graded raw materials and long-standing manufacturing know-how. The company analyzed preferred textures, aromas, and thicknesses across different consumer segments and distribution channels, then selected suitable raw materials to reflect these preferences in each product. Daingt also sought to differe
- 김갑성 기자
- 2026-01-04 08:00
-
Rising Through Challenge: Living Phoenix's 2026 New Year M…
CHENGDU, China, Jan. 1, 2026 -- As the Year of the Horse begins, bringing new momentum and promise, Living Phoenix—a pioneer in next-generation biomaterials—wishes all friends, partners, and users a joyful New Year. May you stay young, steady, and ready to gallop forward into 2026. Qin Xingjiong, founder of Living Phoenix, was invited as a representative of the innovation team to attend the AbbVie & Allergan China Open Day, where he shared insights on recent advancements and industry applications in trimeric collagen technology. From User Experience to Trust&n
- 김갑성 기자
- 2026-01-01 12:36
-
POGMENT Biomimic Collagen Reacquired Recognition, Found…
CHENGDU, China, Dec. 31, 2025 -- On December 27, the 2025 Master of Engineering Management (MEM) Industry Mentor Orientation and Appointment Ceremony was held at the Wenshi Building on the Putuo Campus of East China Normal University (ECNU), located at No. 3663 Zhongshan North Road, Putuo District, Shanghai. Qin Xingjiong, founder of LivingPhoenix Regenerative Technology also chairman of the High-Tech & Supply Chain Branch of the China Association of Plastic Surgery, was formally appointed as an industry mentor for master's students. Professor He Jiaxun—PhD supervisor, prof
- 김갑성 기자
- 2025-12-31 17:21
-
Life-Space TrioBiotic Series Lands in Southeast Asia, Revol…
BANGKOK, Dec. 31, 2025 -- A significant shift is underway in the regional health and wellness landscape as the innovative Life-Space TrioBiotic supplement series officially enters the Southeast Asian market. The launch introduces a cutting-edge "three-in-one" approach to gut health, combining prebiotics, probiotics, and postbiotics in a single daily dose. The world of health and wellness has been fundamentally transformed by the pivotal role of Probiotics in supporting gut health and overall well-being. Over the past decade, we have witnessed an explosive surge in probiotic-b
- 김갑성 기자
- 2025-12-31 15:46
-
KLMBio Accelerates Global Expansion in Bone Graft Market wi…
SEOUL, South Korea, Dec. 31, 2025 -- KLMBio, a manufacturer and exporter of human tissue-based medical devices, is accelerating its global business expansion by strengthening its high-value tissue-based product portfolio to target the rapidly growing global bone graft market. The global bone graft market is a high-growth medical device sector, driven by steadily increasing usage in orthopedic surgery, spinal procedures, and dental implants. The market is projected to reach approximately USD 6.66 billion by 2032. In particular, human tissue-based products continue to gain market prefere
- 김갑성 기자
- 2025-12-31 12:44
-
Qiming Venture Partners' Insilico Medicine Successfully List…
SHANGHAI, Dec. 31, 2025 -- Insilico Medicine (03696.HK), a global leader in AI-driven drug discovery and a portfolio company of Qiming Venture Partners, today successfully listed on the Hong Kong Stock Exchange (HKEX). The listing marks the largest biotech IPO on the Hong Kong stock market in 2025. With an issue price of HK$ 24.05 per share, Insilico Medicine opened at HK$35.00 per share, representing a market capitalization of approximately HK$ 19.51 billion. Qiming Venture Partners is one of Insilico Medicine's most important institutional investors. Qiming Venture Partners led the C
- 김갑성 기자
- 2025-12-31 08:55
-
Entering the New Year, VARON Strengthens Commitment to Depe…
NEW YORK, Dec. 31, 2025 -- As the new year begins, it offers a meaningful moment to reflect on shared progress and renewed responsibility in respiratory care. Over the past year, VARON has continued to focus on what matters most—reliability, accessibility, and compassion-driven action that supports real people and real needs. A Year Shaped by Reliability and Everyday Care The past year reinforced the growing importance of dependable oxygen therapy solutions. For many individuals and families, access to an oxygen concentrator for home use has become essentia
- 김갑성 기자
- 2025-12-31 07:34
-
Mabwell Announces First Patient Dosed in Phase II Trial of An…
SHANGHAI, Dec. 30, 2025 -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that the Phase II clinical trial of its self-developed innovative anti-IL-11 monoclonal antibody (R&D code: 9MW3811) for pathological scarring recently completed the first patient dosing in China, becoming the world's first IL-11 targeting drug candidate to initiate clinical trials for pathological scarring. This Phase II clinical trial (CTR20254857) aims to evaluate the safety, tolerability, pharmacokinetics, and preliminary efficacy of 9
- 김갑성 기자
- 2025-12-30 22:00
-
China's Sleep Technology Pioneer Sleemon Draws Increas…
SHAOXING, China, Dec. 30, 2025 -- A long-established household brand in China with a comparatively limited international profile, Sleemon Healthy Sleep Technology Co., Ltd. is gaining attention from the global technology community as it expands its focus on advanced sleep technology solutions. Founded in 1984, Sleemon was the first mattress manufacturer in China to list publicly (SSE: 603008). While the company adopted its current corporate name in recent years, it has long been recognized in the domestic market for its leadership and sustained investment in sleep technology. In
- 김갑성 기자
- 2025-12-30 21:54
- 1포리프 굿마팻 (누바디 굿바이 마이팻) 다이어트 건강기능식품 출시
- 22021년 식품분석전문가 1급/2급 검정자격시험 안내
- 3투썸플레이스, 초콜릿 애프리콧 무스 출시
- 4아임웹, CRM 기능 출시… 고객 행동 데이터 기반 마케팅 지원
- 5하만카돈, AURA STUDIO 4 블루투스 스피커 출시
- 6대구오페라하우스 - 20주년 기념 골든 보이스 시리즈Ⅲ, 테너 콘서트
- 7만성질환자들의 유료독감백신접종에 정책적인 배려가 필요하다
- 82021년 대학생기자단 모집
- 9대한약물영양의학회 2020년 추계학술대회
- 10대한영양제처방학회 춘계학술대회 성황리에 마쳐
2026-01-31_SAT
- Sanyou Bio's Decade: From an Intelligent Super-Trillion Antibody Library to the "Innovation Hub for Original Drug Discovery" 16:15
- CANADA BACKS NEW DEFENCE, SECURITY AND RESILIENCE BANK 12:05
- Origin Agritech Announces Fiscal Year 2025 Results 06:00
- White Pearl Acquisition Corp. Announces Pricing of $100 Million Initial Public Offering 05:47
- Planet Green Holdings Corp. Provides Response to Unusual Market Action 05:05
- SKF completes previously announced divestment of non-core aerospace operation in Elgin, USA 03:36
- DOCOMO Concludes Partnership Agreement with Aduna to Advance Global Network API Expansion 03:34
발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.
UPDATE: 2026년 01월 31일 17시 40분